125 related articles for article (PubMed ID: 33901694)
1. Natural History of Incidental Enhancing Nodules on Cone-Beam Computed Tomography during Transarterial Therapy of Hepatocellular Carcinoma.
Elboraey M; Devcic Z; Montazeri SA; Li X; Lewis AR; Ritchie CA; Frey GT; Paz-Fumagalli R; McKinney JM; Toskich BB
J Vasc Interv Radiol; 2021 Aug; 32(8):1186-1192.e1. PubMed ID: 33901694
[TBL] [Abstract][Full Text] [Related]
2. The Efficacy of Cone-Beam CT-Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization.
Kim KA; Choi SY; Kim MU; Baek SY; Park SH; Yoo K; Kim TH; Kim HY
J Vasc Interv Radiol; 2019 Mar; 30(3):358-369. PubMed ID: 30819478
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Accuracy of Split-Bolus Single-Phase Contrast-Enhanced Cone-Beam CT for the Detection of Liver Tumors before Transarterial Chemoembolization.
Jonczyk M; Chapiro J; Collettini F; Geisel D; Schnapauff D; Streitparth F; Schmidt T; Hamm B; Gebauer B; Wieners G
J Vasc Interv Radiol; 2017 Oct; 28(10):1378-1385. PubMed ID: 28747271
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Image Quality and Diagnostic Performance of Cone-Beam CT during Drug-Eluting Embolic Transarterial Chemoembolization and Multidetector CT in the Detection of Hepatocellular Carcinoma.
Lucatelli P; Argirò R; Ginanni Corradini S; Saba L; Cirelli C; Fanelli F; Ricci C; Levi Sandri GB; Catalano C; Bezzi M
J Vasc Interv Radiol; 2017 Jul; 28(7):978-986. PubMed ID: 28495451
[TBL] [Abstract][Full Text] [Related]
5. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor response.
Suk Oh J; Jong Chun H; Gil Choi B; Giu Lee H
J Vasc Interv Radiol; 2013 Apr; 24(4):483-9. PubMed ID: 23452553
[TBL] [Abstract][Full Text] [Related]
6. Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: How to Pursue Periprocedural Cross-Sectional Imaging?
Ruff C; Grözinger G; Syha R; Elser S; Partovi S; Bitzer M; Horger M; Nikolaou K; Grosse U
J Vasc Interv Radiol; 2019 Mar; 30(3):380-389.e4. PubMed ID: 30819480
[TBL] [Abstract][Full Text] [Related]
7. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
[TBL] [Abstract][Full Text] [Related]
8. Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma?
Loffroy R; Lin M; Yenokyan G; Rao PP; Bhagat N; Noordhoek N; Radaelli A; Blijd J; Liapi E; Geschwind JF
Radiology; 2013 Feb; 266(2):636-48. PubMed ID: 23143027
[TBL] [Abstract][Full Text] [Related]
9. Early prediction of 1-year tumor response of hepatocellular carcinoma with lipiodol deposition pattern through post-embolization cone-beam computed tomography during conventional transarterial chemoembolization.
Tsai YC; Shih JH; Hwang HE; Chiu NC; Lee RC; Tseng HS; Liu CA
Eur Radiol; 2021 Oct; 31(10):7464-7475. PubMed ID: 33765160
[TBL] [Abstract][Full Text] [Related]
10. The Role of Dual-Phase Cone-Beam CT in Predicting Short-Term Response after Transarterial Chemoembolization for Hepatocellular Carcinoma.
Müller K; Datta S; Gehrisch S; Ahmad M; Mohammed MA; Rosenberg J; Hwang GL; Louie JD; Sze DY; Kothary N
J Vasc Interv Radiol; 2017 Feb; 28(2):238-245. PubMed ID: 27914917
[TBL] [Abstract][Full Text] [Related]
11. Cone Beam CT-Guided Chemoembolization of Probable Hepatocellular Carcinomas Smaller than 1 cm in Patients at High Risk of Hepatocellular Carcinoma.
Choi JW; Kim HC; Lee JH; Yu SJ; Cho EJ; Kim MU; Hur S; Lee M; Jae HJ; Chung JW
J Vasc Interv Radiol; 2017 Jun; 28(6):795-803.e1. PubMed ID: 28302348
[TBL] [Abstract][Full Text] [Related]
12. Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with response.
Hu J; Maybody M; Cao G; Wang X; Chen H; Zhu X; Yang R; Wang X
Cancer Imaging; 2016 Oct; 16(1):32. PubMed ID: 27716376
[TBL] [Abstract][Full Text] [Related]
13. Cone-beam CT hepatic arteriography in chemoembolization for hepatocellular carcinoma: angiographic image quality and its determining factors.
Lee IJ; Chung JW; Yin YH; Kim HC; Kim YI; Jae HJ; Park JH
J Vasc Interv Radiol; 2014 Sep; 25(9):1369-79; quiz 1379-.e1. PubMed ID: 24925087
[TBL] [Abstract][Full Text] [Related]
14. Cone-Beam CT-Guided Chemoembolization in Patients with Complete Response after Previous Chemoembolization but Subsequent Elevated α-Fetoprotein without Overt Hepatocellular Carcinoma.
Wattanasatesiri T; Kim HC; Choi JW; Lee JH; Joo I; Hur S; Lee M; Jae HJ; Chung JW
J Vasc Interv Radiol; 2019 Aug; 30(8):1273-1280. PubMed ID: 31235410
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of fusion images of unenhanced and contrast-enhanced arterial phase cone-beam CT in the detection of viable hepatocellular carcinoma during transarterial chemoembolization.
Kim EH; Oh JS; Chun HJ; Choi BG; Lee HG
Diagn Interv Radiol; 2018 Sep; 24(5):262-267. PubMed ID: 30211679
[TBL] [Abstract][Full Text] [Related]
16. Comparing the detectability of hepatocellular carcinoma by C-arm dual-phase cone-beam computed tomography during hepatic arteriography with conventional contrast-enhanced magnetic resonance imaging.
Loffroy R; Lin M; Rao P; Bhagat N; Noordhoek N; Radaelli A; Blijd J; Geschwind JF
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):97-104. PubMed ID: 21328023
[TBL] [Abstract][Full Text] [Related]
17. The Role of Cone-Beam CT in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Pung L; Ahmad M; Mueller K; Rosenberg J; Stave C; Hwang GL; Shah R; Kothary N
J Vasc Interv Radiol; 2017 Mar; 28(3):334-341. PubMed ID: 28109724
[TBL] [Abstract][Full Text] [Related]
18. Iodized oil uptake assessment with cone-beam CT in chemoembolization of small hepatocellular carcinomas.
Jeon UB; Lee JW; Choo KS; Kim CW; Kim S; Lee TH; Jeong YJ; Kang DH
World J Gastroenterol; 2009 Dec; 15(46):5833-7. PubMed ID: 19998505
[TBL] [Abstract][Full Text] [Related]
19. Dual-phase Cone-beam CT-based Navigation Imaging Significantly Enhances Tumor Detectability and Aids Superselective Transarterial Chemoembolization of Liver Cancer.
Yao X; Yan D; Jiang X; Li X; Zeng H; Liu D; Li H
Acad Radiol; 2018 Aug; 25(8):1031-1037. PubMed ID: 29398432
[TBL] [Abstract][Full Text] [Related]
20. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
